Valeo Financial Advisors, LLC Evolus, Inc. Transaction History

Valeo Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 13, 2020	SELL	$3.53 - $12.21 $25,416 - $87,912	-7,200 Closed	0 $0
Q4 2019 Jan 24, 2020	BUY	$11.58 - $17.37 $83,376 - $125,064	7,200 New	7,200 $88,000
Q3 2019 Oct 15, 2019	SELL	$13.91 - $19.87 $101,543 - $145,051	-7,300 Closed	0 $0
Q2 2019 Jul 10, 2019	BUY	$13.19 - $28.36 $32,975 - $70,900	2,500 Added 52.08%	7,300 $107,000
Q1 2019 Apr 12, 2019	BUY	$12.43 - $28.91 $59,664 - $138,768	4,800 New	4,800 $108,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $610M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.